NPPB and diabetes mellitus: As the PONTIAC study demonstrated, in patients with type 2 diabetes mellitus and a NT-proBNP level > 125 pg/mL, up-titration of RAS antagonists and beta-blockers significantly reduced the primary outcome of 2-year CV mortality and hospitalizations [31].